Alethea Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
|
|||||
|
2025
Q1 | $12.4M | Buy |
|
|||||
|
2024
Q4 | $12.2M | Sell |
|
|||||
|
2024
Q3 | $19.6M | Sell |
|
|||||
|
2024
Q2 | $20.6M | Sell |
|
|||||
|
2024
Q1 | $19.4M | Sell |
|
|||||
|
2023
Q4 | $7.73M | Hold |
|
|||||
|
2023
Q3 | $5.45M | Buy |
|
|||||
|
2023
Q2 | $9.42M | Hold |
|
|||||
|
2023
Q1 | $13M | Buy |
|
|||||
|
2022
Q4 | $18.3M | Sell |
|
|||||
|
2022
Q3 | $13.6M | Hold |
|
|||||
|
2022
Q2 | $12.1M | Sell |
|
|||||
|
2022
Q1 | $16.4M | Buy |
|
|||||
|
2021
Q4 | $21.1M | Sell |
|
|||||
|
2021
Q3 | $22.4M | Sell |
|
|||||
|
2021
Q2 | $28.8M | Sell |
|
|||||
|
2021
Q1 | $30.2M | Sell |
|
|||||
|
2020
Q4 | $40.1M | Buy |
|